Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Follow-Up Questions
What is the price performance of MDDVF stock?
The current price of MDDVF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Medical Developments International Ltd?
Medical Developments International Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Medical Developments International Ltd market cap?
Medical Developments International Ltd's current market cap is $0
Is Medical Developments International Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Medical Developments International Ltd, including 1 strong buy, 3 buy, 1 hold, 0 sell, and 1 strong sell
